These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36974408)

  • 1. Central Sensitization in Spondyloarthritis: The Crossroads between Disease Activity, Health-related Quality of Life and Fibromyalgia.
    Aicha BT; Ines C; Olfa S; Selma B; Leila R; Rawdha T; Ines M; Leila A
    Curr Rheumatol Rev; 2023; 19(4):479-487. PubMed ID: 36974408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central sensitization has major impact on quality of life in patients with axial spondyloarthritis.
    Kieskamp SC; Paap D; Carbo MJG; Wink F; Bos R; Bootsma H; Arends S; Spoorenberg A
    Semin Arthritis Rheum; 2022 Feb; 52():151933. PubMed ID: 35033996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between central sensitization and disease activity, quality of life, and sleep quality among patients with axial spondyloarthritis.
    Aykurt Karlıbel I; Kasapoğlu Aksoy M
    Ir J Med Sci; 2023 Feb; 192(1):481-489. PubMed ID: 35226249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibromyalgia in Spondyloarthritis: Effect on Disease Activity Assessment in Clinical Practice.
    Wach J; Letroublon MC; Coury F; Tebib JG
    J Rheumatol; 2016 Nov; 43(11):2056-2063. PubMed ID: 27633820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biopsychosocial factors should be considered when evaluating central sensitization in axial spondyloarthritis.
    Sariyildiz A; Coskun Benlidayi I; Turk I; Zengin Acemoglu SS; Unal I
    Rheumatol Int; 2023 May; 43(5):923-932. PubMed ID: 36966430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of self-esteem and community integration in spondyloarthritis.
    Aicha BT; Lobna BA; Yosra Z; Siwar BD; Ines C; Selma B; Leila R; Rawdha T; Olfa S; Ines M; Leila A
    Reumatol Clin (Engl Ed); 2023; 19(6):299-305. PubMed ID: 37286265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central sensitization, illness perception and obesity should be considered when interpreting disease activity in axial spondyloarthritis.
    Kieskamp SC; Paap D; Carbo MJG; Wink F; Bos R; Bootsma H; Arends S; Spoorenberg A
    Rheumatology (Oxford); 2021 Oct; 60(10):4476-4485. PubMed ID: 33492397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between psychiatric status, self-reported outcome measures, and clinical parameters in axial spondyloarthritis.
    Kilic G; Kilic E; Ozgocmen S
    Medicine (Baltimore); 2014 Dec; 93(29):e337. PubMed ID: 25546683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The important role of central sensitization in chronic musculoskeletal pain seen in different rheumatic diseases.
    Guler MA; Celik OF; Ayhan FF
    Clin Rheumatol; 2020 Jan; 39(1):269-274. PubMed ID: 31446538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive Performance Is Related to Central Sensitization and Health-related Quality of Life in Patients with Chronic Whiplash-Associated Disorders and Fibromyalgia.
    Coppieters I; Ickmans K; Cagnie B; Nijs J; De Pauw R; Noten S; Meeus M
    Pain Physician; 2015; 18(3):E389-401. PubMed ID: 26000686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the Central Sensitization Inventory (CSI) as a treatment outcome measure for patients with chronic spinal pain disorder in a functional restoration program.
    Neblett R; Hartzell MM; Williams M; Bevers KR; Mayer TG; Gatchel RJ
    Spine J; 2017 Dec; 17(12):1819-1829. PubMed ID: 28619687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burden of disease, pain catastrophizing, and central sensitization in relation to work-related issues in young spondyloarthritis patients.
    Ben Tekaya A; Ben Said H; Yousfi I; Ben Dhia S; Bouden S; Rouached L; Mahmoud I; Tekaya R; Saidane O; Abdelmoula L
    Reumatologia; 2024; 62(1):35-42. PubMed ID: 38558896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determining factors related to poor quality of life in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register (BSRBR-AS).
    Macfarlane GJ; Rotariu O; Jones GT; Pathan E; Dean LE
    Ann Rheum Dis; 2020 Feb; 79(2):202-208. PubMed ID: 31662321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibromyalgia in Spondyloarthritis: Prevalence and Effect on Disease Activity and Treatment.
    Olfa S; Bouden S; Sahli M; Tekaya AB; Rouached L; Rawdha T; Mahmoud I; Abdelmoula L
    Curr Rheumatol Rev; 2023; 19(2):214-221. PubMed ID: 36056847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of quality of life in patients with axial spondyloarthritis and its association with disease activity, functionality, mobility, and structural damage.
    López-Medina C; Garrido-Castro JL; Castro-Jiménez J; González-Navas C; Calvo-Gutiérrez J; Castro-Villegas MC; Ortega-Castro R; Escudero-Contreras A; Font-Ugalde P; Collantes-Estévez E
    Clin Rheumatol; 2018 Jun; 37(6):1581-1588. PubMed ID: 29691772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of the Central Sensitization Inventory compared with traditional measures of disease severity in fibromyalgia.
    Salaffi F; Farah S; Mariani C; Sarzi-Puttini P; Di Carlo M
    Pain Pract; 2022 Nov; 22(8):702-710. PubMed ID: 36097821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishing Clinically Relevant Severity Levels for the Central Sensitization Inventory.
    Neblett R; Hartzell MM; Mayer TG; Cohen H; Gatchel RJ
    Pain Pract; 2017 Feb; 17(2):166-175. PubMed ID: 26989894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convergent validity of the central sensitization inventory in women with fibromyalgia: Association with clinical, psychological and psychophysical outcomes.
    Valera-Calero JA; Úbeda-D'Ocasar E; Arias-Buría JL; Fernández-de-Las-Peñas C; Gallego-Sendarrubias GM; Cigarán-Méndez M
    Eur J Pain; 2022 Nov; 26(10):2141-2151. PubMed ID: 35979630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutoff Value for Short Form of Central Sensitization Inventory.
    Tanaka K; Nishigami T; Mibu A; Manfuku M; Yono S; Yukioka M; Miki K
    Pain Pract; 2020 Mar; 20(3):269-276. PubMed ID: 31638741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Central Sensitization Inventory Score in elderly adults with musculoskeletal examination.
    Ide K; Yasuda T; Hasegawa T; Yamato Y; Yoshida G; Banno T; Arima H; Oe S; Mihara Y; Ushirozako H; Yamada T; Watanabe Y; Nakai K; Hoshino H; Matsuyama Y
    Mod Rheumatol; 2021 Jul; 31(4):885-889. PubMed ID: 32917120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.